ZIRCON: pharmacokinetics, safety, and efficacy of ombitasvir/ paritaprevir/ritonavir ± dasabuvir ± ribavirin in adolescents with genotype 1 or 4 hepatitis C virus infection
2017 ◽
Vol 66
(1)
◽
pp. S300-S301
◽
Keyword(s):